Clinical Trial

Hepcidin and Glucose Metabolism

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia (IDA) are common during pregnancy. Both disease patterns are associated with an increased risk of complications during pregnancy and at delivery and may have a variety of negative effects on different aspects of child development. Thus, GDM and ID/IDA during pregnancy should be prevented. Whether iron supplementation with high oral doses acutely increases hepcidin during pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin sensitivity, is uncertain.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-07-01; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2019-07-15
Trial Details
NCT Number NCT04008147
Lead Sponsor Swiss Federal Institute of Technology
Collaborators: University Hospital, Zürich
Conditions Iron Deficiency Anemia of Pregnancy, Iron Metabolism Disorders, Glucose Intolerance, Gestational Diabetes
Enrollment 30 participants
Start Date 2019-07-03
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22